BennettBChinMD
Nuclear Medicine • Aurora, COAssociate Professor, Radiology, Duke University School of Medicine
Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
OtherClass of 1997- Methodist Health System DallasResidency, Internal Medicine, 1990
University of Texas Medical Branch School of MedicineClass of 1987
Certifications & Licensure
CO State Medical License 2017 - 2025
NC State Medical License 2003 - 2025
MD State Medical License 1995 - 2004
PA State Medical License 1992 - 2002
TX State Medical License 1988 - 1993- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases Start of enrollment: 2009 Sep 01
- Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG Start of enrollment: 2009 Nov 01
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- Attenuated kidney oxidative metabolism in young adults with type 1 diabetes.Ye Ji Choi, Gabriel Richard, Guanshi Zhang, Jeffrey B Hodgin, Dawit S Demeke
The Journal of Clinical Investigation. 2024-10-22 - Improving Generalizability of PET DL Algorithms: List-Mode Reconstructions Improve DOTATATE PET Hepatic Lesion Detection Performance.Xinyi Yang, Michael Silosky, Jonathan Wehrend, Daniel V Litwiller, Muthiah Nachiappan
Bioengineering. 2024-02-27 - 5 citationsBiomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.Camilo Jimenez, Bennett B Chin, Richard B Noto, Joseph S Dillon, Lilja Solnes
Endocrine-Related Cancer. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
